Kelly C Lee1, Karen Suchanek Hudmon, Joseph D Ma, Grace M Kuo. 1. University of California, San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences, 9500 Gilman Drive, Pharmaceutical Sciences Building, La Jolla, CA 92093-0719, USA.
Abstract
AIM: This national dissemination study evaluated pharmacy students' self-reported overall ability, self-efficacy and attitudes toward applying pharmacogenomics and perceptions of Pharmacogenomics Education Program, a shared pharmacogenomics curriculum. PATIENTS & METHODS: Following a series of train-the-trainer programs for pharmacy faculty, pre- (n = 2674) and post-training surveys (n = 2542) were administered to Doctor of Pharmacy students (n = 43 pharmacy schools). RESULTS: Students reported increased (pre- vs post-training) overall ability to educate patients about pharmacogenomics (17 vs 63%; p < 0.0001) and pharmacogenomic testing (11 vs 60%; p < 0.0001) and increased self-efficacy for identifying therapeutic areas for which pharmacogenomic testing is required (20 vs 75%; p < 0.0001). Most (92%) agreed that students at other schools would benefit from receiving the same, or similar, pharmacogenomics education. CONCLUSION: A shared curriculum is an effective approach for broadscale curricular dissemination. Original submitted 17 October 2014; Revision submitted 19 December 2014.
AIM: This national dissemination study evaluated pharmacy students' self-reported overall ability, self-efficacy and attitudes toward applying pharmacogenomics and perceptions of Pharmacogenomics Education Program, a shared pharmacogenomics curriculum. PATIENTS & METHODS: Following a series of train-the-trainer programs for pharmacy faculty, pre- (n = 2674) and post-training surveys (n = 2542) were administered to Doctor of Pharmacy students (n = 43 pharmacy schools). RESULTS: Students reported increased (pre- vs post-training) overall ability to educate patients about pharmacogenomics (17 vs 63%; p < 0.0001) and pharmacogenomic testing (11 vs 60%; p < 0.0001) and increased self-efficacy for identifying therapeutic areas for which pharmacogenomic testing is required (20 vs 75%; p < 0.0001). Most (92%) agreed that students at other schools would benefit from receiving the same, or similar, pharmacogenomics education. CONCLUSION: A shared curriculum is an effective approach for broadscale curricular dissemination. Original submitted 17 October 2014; Revision submitted 19 December 2014.
Authors: Kristin Wiisanen Weitzel; Caitrin W McDonough; Amanda R Elsey; Benjamin Burkley; Larisa H Cavallari; Julie A Johnson Journal: Am J Pharm Educ Date: 2016-09-25 Impact factor: 2.047
Authors: Solomon M Adams; Kacey B Anderson; James C Coons; Randall B Smith; Susan M Meyer; Lisa S Parker; Philip E Empey Journal: Am J Pharm Educ Date: 2016-02-25 Impact factor: 2.047
Authors: Mary W Roederer; Grace M Kuo; David F Kisor; Reginald F Frye; James M Hoffman; Jean Jenkins; Kristin Wiisanen Weitzel Journal: J Am Pharm Assoc (2003) Date: 2016-11-03
Authors: Kristin Wiisanen Weitzel; Christina L Aquilante; Samuel Johnson; David F Kisor; Philip E Empey Journal: Am J Health Syst Pharm Date: 2016-12-01 Impact factor: 2.637
Authors: Chandrama Mukherjee; Kevin M Sweet; Jasmine A Luzum; Mahmoud Abdel-Rasoul; Michael F Christman; Joseph P Kitzmiller Journal: Per Med Date: 2017-09-01 Impact factor: 2.512
Authors: Amber Frick; Cristina S Benton; Kelly L Scolaro; Jacqueline E McLaughlin; Courtney L Bradley; Oscar T Suzuki; Nan Wang; Tim Wiltshire Journal: Front Pharmacol Date: 2016-08-08 Impact factor: 5.810